The Drug That Left A French Test Subject Brain Dead Wasn't Cannabis

Many news organizations rushed to report on a drug trial in France that went horribly wrong, leaving six hospitalized, including one man described as "brain dead."

Some early reports of the unfortunate incident indicated that the drug being used in the trial contained cannabidiol (CBD), an active cannabinoid found in cannabis.

French Health Minister Marisol Touraine held a press conference in Rennes today vowing "to get to the bottom of this tragic incident." But she has already determined one thing: the drug is not related to cannabis and did not contain CBD.

The drug being tested, developed by a Portuguese pharmaceutical company named Bial, was intended to be administered orally and was reported to be in testing for use in combatting degenerative diseases.

h/t WSJ, CBC


Most people know that to consume alcohol and then get behind the wheel of a car is very dangerous — not just for the driver and passengers, but for anyone else sharing the road. For cannabis consumers, however, understanding levels of impairment is not so straightforward. To date, there is not yet a technology used by law enforcement that can accurately detect cannabis impairment similar to alcohol breathalyzers.

Can we see some ID please?

You must be 19 years of age or older to enter.